Authors

• Erika Hamilton (ORCID: https://orcid.org/0000-0002-1911-0336)
• Laura Brennan
• José Duarte (ORCID: https://orcid.org/0000-0002-5641-0928)
• George Au‐Yeung (ORCID: https://orcid.org/0000-0003-1128-6385)
• Mark DeMario
• Iakov I. Davydov (ORCID: https://orcid.org/0000-0003-3510-3926)
• Stéphanie Lheureux (ORCID: https://orcid.org/0000-0003-4405-5890)
• Sabine Wilson
• Daniel Marbach (ORCID: https://orcid.org/0000-0002-6686-9249)
• Bruno Gomes (ORCID: https://orcid.org/0000-0002-5569-0526)
• Evelyne Chesné (ORCID: https://orcid.org/0000-0002-4578-6479)
• Eveline Nüesch
• Nicolas Staedler
• Marta Cañamero (ORCID: https://orcid.org/0000-0003-2239-4285)
• Izolda Franjkovic
• Iben Spanggaard (ORCID: https://orcid.org/0000-0001-5925-2630)
• Martin Kornacker (ORCID: https://orcid.org/0000-0002-3502-928X)
• Katharina Lechner (ORCID: https://orcid.org/0000-0002-3582-3512)
• Debra L. Richardson (ORCID: https://orcid.org/0000-0002-3992-8610)
• Iris Martinez Quetglas (ORCID: https://orcid.org/0009-0009-9558-1517)
• Jurriaan Brouer-Visser

Institutions

• Roche (Switzerland) (CH)
• University Health Network (CA)
• The University of Melbourne (AU)
• University of Toronto (CA)
• Peter MacCallum Cancer Centre (AU)
• Copenhagen University Hospital (DK)
• Princess Margaret Cancer Centre (CA)
• Rigshospitalet (DK)
• Roche Pharma AG (Germany) (DE)
• Sarah Cannon (US)
• University of Oklahoma Health Sciences Center (US)
• La Roche College (US)

Publication Details

Journal

BMC Cancer

Published

2025-03-18

DOI

https://doi.org/10.1186/s12885-025-13851-4

Citations

6

Primary Topic

Protein Degradation and Inhibitors

Type

article

Field-Weighted Citation Impact

4.84